Kevin Caili Wang
11Patents
5h-index
34Co-inventors
62Inventor score
Filing activity: Nov 26, 2003 → Jul 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8188234B2 | 1D05 PCSK9 antagonists | Chemistry; Metallurgy | 87 | Active |
| US8188233B2 | 1B20 PCSK9 antagonists | Chemistry; Metallurgy | 81 | Active |
| US7667004B2 | Humanized antibodies against vascular endothelial growth factor | Emerging Cross-Sectional Technologies | 39 | Expired |
| US8697070B2 | 1D05 PCSK9 antagonists | Chemistry; Metallurgy | 13 | Active |
| US7462698B2 | Anti-CD26 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US8030469B2 | Anti-CD26 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US8802827B2 | AX1 PCSK9 antagonists | Chemistry; Metallurgy | 3 | Active |
| USD925812S1 | Dome light | General | 3 | Active |
| US8957194B2 | 1B20 PCSK9 antagonists | Chemistry; Metallurgy | 2 | Active |
| US11180536B2 | Antibodies to royalactin and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8637435B2 | Eukaryotic cell display systems | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.